1. A medical condition, other than PBC, that in the investigator's opinion would preclude full participation in the study or confound its results (e.g., cancer on active treatment) 
2. AST or ALT > 3 × ULN 
3. Total bilirubin > 2 × ULN 
4. Auto-immune hepatitis 
5. Primary sclerosing cholangitis 
6. Known history of alpha-1-Antitrypsin deficiency 
7. Known history of chronic viral hepatitis 
8. Creatine kinase above ULN 
9. Serum creatinine above ULN 
10. For females, pregnancy or breast-feeding 
11. Use of colchicine, methotrexate, azathioprine, or systemic steroids in the two months preceding screening 
12. Current use of fibrates, including fenofibrates, or simvastatin 
13. Use of an experimental treatment for PBC 
14. Use of experimental or unapproved immunosuppressant 
15. Any other condition(s) that would compromise the safety of the subject or compromise the quality of the clinical study, as judged by the Investigator       
    
